All News #Library
Rare Diseases
MTP America Receives U.S. FDA Orphan Drug Exclusivity for RADICAVA
08 Apr 2024 //
PR NEWSWIRE
Mitsubishi Tanabe America gets US FDA orphan drug exclusivity Radicava ORS
08 Apr 2024 //
PHARMABIZ

Market Place
Sourcing Support